Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for ...

Merck’s Keytruda may be the most talked about drug facing loss of exclusivity but it’s far from the only one, as several of ...

Foods IBS Provides Personalized Diet Therapy for Patients Suffering with Irritable Bowel Syndrome (IBS) Research Finds Patients Following a Personalized Diet Therapy Created wit ...

Kent Lake PR LLC ("Kent Lake"), a holder of 5.9% of the outstanding common stock of Quanterix Corporation ("Quanterix" or the "Company") (NASDAQ: QTRX), today highlighted its opposition to the Company ...

C3i Center (C3i) announces that it has obtained regulatory approval from the EMA (European Medicine Agency) to produce cell therapy treatments for the European market. C3i, therefore, obtains a ...

"Net sales increased during the fourth quarter by 41.5 percent to SEK 64.2 million, compared with the corresponding quarter of 2023. The growth and strong performance are a result of robust developmen ...

Imagion Biosystems has initiated manufacturing of its MagSense imaging agent for its phase II clinical study on HER2+ breast ...

Traditional mammograms have long been the gold standard for breast cancer detection, but they aren't always perfect.

The implant attracts diseased immune cells, enabling researchers to study and target them with a nanoparticle-based treatment The design of the ...

With underlying earnings growth of 7%, chemist owner and supplier EBOS Group is tapping healthy conditions in the sector. ...

Big news is getting investors excited on Wednesday. Let's find out what is happening. The post 2 ASX 200 pharmaceutical ...